Cargando…
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
The most frequent genetic alterations of the TP53 gene in human cancer were reported. TP53 mutation gains new function as a target of genetic instability, which is associated with increased tumor progression and poor survival rate in patients. In this study, more than three hundred colorectal cancer...
Autores principales: | Liu, Nannan, Jiang, Xinxiu, Guo, Leiming, Zhang, Chuchu, Jiang, Meimei, Sun, Zhuoran, Zhang, Yizheng, Mi, Wunan, Li, Jiehan, Fu, Yang, Wang, Feng, Zhang, Lingling, Zhang, Yingjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990467/ https://www.ncbi.nlm.nih.gov/pubmed/35414774 http://dx.doi.org/10.7150/ijbs.67200 |
Ejemplares similares
-
Targeting ERK induced cell death and p53/ROS-dependent protective autophagy in colorectal cancer
por: Mi, Wunan, et al.
Publicado: (2021) -
Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth
por: Zhang, Yizheng, et al.
Publicado: (2022) -
In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy
por: Li, Jiehan, et al.
Publicado: (2022) -
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246
por: Zhou, Xiaolei, et al.
Publicado: (2022) -
Gain-of-function mutant p53 in cancer progression and therapy
por: Zhang, Cen, et al.
Publicado: (2020)